SENP1 and breast cancer: Claudin 6 (CLDN6) appears to be able to regulate the HIF-1α pathway through SENP1 in BC cells and BC patients with primary CLDN6 loss are more prone to have tumor metastasis, due to a lack of feedback mechanism that impairs HIF-1α stability.